{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:18:52Z","timestamp":1740140332812,"version":"3.37.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["VA138G18"],"award-info":[{"award-number":["VA138G18"]}],"id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["MTM2014-56022-C2-2-P"],"award-info":[{"award-number":["MTM2014-56022-C2-2-P"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["MTM2017-85476-C2-1-P"],"award-info":[{"award-number":["MTM2017-85476-C2-1-P"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["VA041P17"],"award-info":[{"award-number":["VA041P17"]}],"id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["VA148G18"],"award-info":[{"award-number":["VA148G18"]}],"id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Theor Biol Med Model"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12976-019-0106-4","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T14:03:08Z","timestamp":1559052188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effects of time valuation in cancer optimal therapies: a study of chronic myeloid leukemia"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4816-615X","authenticated-orcid":false,"given":"Pedro Jos\u00e9","family":"Guti\u00e9rrez-Diez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"L\u00f3pez-Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Mart\u00ednez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"issue":"2","key":"106_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/00207160903443755","volume":"88","author":"G Magombedze","year":"2011","unstructured":"Magombedze G, Garira W, Mwenje E, Bhunu CP. Optimal control for HIV-1 multi-drug therapy. Int J Comput Math. 2011; 88(2):314\u201340.","journal-title":"Int J Comput Math"},{"issue":"15","key":"106_CR2","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1080\/00207160.2011.583349","volume":"88","author":"N Tarfulea","year":"2011","unstructured":"Tarfulea N. A mathematical model for HIV treatment with time-varying antiretroviral therapy. Int J Comput Math. 2011; 88(15):3217\u201335.","journal-title":"Int J Comput Math"},{"key":"106_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1742-4682-11-41","volume":"11","author":"Y Koizumi","year":"2014","unstructured":"Koizumi Y, Iwami S. Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal 572 combinations of antiviral drugs. Theor Biol Med Model. 2014; 11:41.","journal-title":"Theor Biol Med Model"},{"key":"106_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-66207-2","volume-title":"Modeling and Control in the Biomedical Sciences.","author":"HT Banks","year":"1975","unstructured":"Banks HT. Modeling and Control in the Biomedical Sciences.Berlin-Heidelberg-New York: Springer-Verlag; 1975."},{"key":"106_CR5","doi-asserted-by":"crossref","DOI":"10.1007\/b98868","volume-title":"Mathematical Biology I: An Introduction","author":"JD Murray","year":"2002","unstructured":"Murray JD. Mathematical Biology I: An Introduction. Berlin-Heidelberg: Springer-Verlag; 2002."},{"key":"106_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/b98869","volume-title":"Mathematical Biology II: Spatial Models and Biomedical Applications","author":"JD Murray","year":"2003","unstructured":"Murray JD. Mathematical Biology II: Spatial Models and Biomedical Applications. Berlin-Heidelberg: Springer-Verlag; 2003."},{"key":"106_CR7","volume-title":"Mathematical Bioeconomics. The Optimal Management of Renewable Resources","author":"CW Clark","year":"1990","unstructured":"Clark CW. Mathematical Bioeconomics. The Optimal Management of Renewable Resources. New York: Wiley; 1990."},{"key":"106_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-4178-6","volume-title":"Mathematical methods and models in Biomedicine","author":"U Ledzewicz","year":"2013","unstructured":"Ledzewicz U, Sch\u00e4ttler H, Friedman A, Kashdan E. Mathematical methods and models in Biomedicine. New York: Springer; 2013."},{"key":"106_CR9","volume-title":"Mathematical Methods and Models in the Biological Sciences.","author":"M Eisen","year":"1988","unstructured":"Eisen M. Mathematical Methods and Models in the Biological Sciences.New Jersey: Prentice Hall; 1988."},{"key":"106_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-2397-3","volume-title":"The Evolution of the Use of Mathematics in Cancer Research.","author":"PJ Guti\u00e9rrez Diez","year":"2012","unstructured":"Guti\u00e9rrez Diez PJ, Russo HI, Russo J. The Evolution of the Use of Mathematics in Cancer Research.New York: Springer; 2012."},{"issue":"3","key":"106_CR11","first-page":"357","volume":"13","author":"A \u015awierniak","year":"2003","unstructured":"\u015awierniak A, Ledzewicz U, Sch\u00e4ttler H. Optimal Control for a Class of Compartmental Models in Cancer Chemotherapy. Int J Appl Math Comput Sci. 2003; 13(3):357\u201368.","journal-title":"Int J Appl Math Comput Sci"},{"issue":"2","key":"106_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0025-5564(90)90129-M","volume":"98","author":"JM Murray","year":"1990","unstructured":"Murray JM. Optimal control for a cancer chemotherapy problem with general growth and cost functions. Math Biosci. 1990; 98(2):273\u201387.","journal-title":"Math Biosci"},{"issue":"1","key":"106_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0025-5564(90)90047-3","volume":"100","author":"JM Murray","year":"1990","unstructured":"Murray JM. Some optimal control problems in cancer chemotherapy with a toxicity limit. Math Biosci. 1990; 100(1):49\u201367.","journal-title":"Math Biosci"},{"issue":"1","key":"106_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mbs.2007.05.003","volume":"210","author":"S Nanda","year":"2007","unstructured":"Nanda S, Moore H, Lenhart S. Optimal control of treatment in a mathematical model of chronic myelogenous leukemia. Math Biosci. 2007; 210(1):143\u201356.","journal-title":"Math Biosci"},{"issue":"2","key":"106_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mbs.2010.06.005","volume":"227","author":"BE A\u00efnseba","year":"2010","unstructured":"A\u00efnseba BE, Benosman C. Optimal control for resistance and suboptimal response in CML. Math Biosci. 2010; 227(2):81\u201393.","journal-title":"Math Biosci"},{"issue":"3","key":"106_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","volume":"13","author":"K Schepers","year":"2013","unstructured":"Schepers K, Pietras EM, Reynaud D, Flach J, Binnewies M, Garg T, Wagers AJ, Hsiao EC, Passegu\u00e9 E. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell. 2013; 13(3):285\u201399.","journal-title":"Cell Stem Cell"},{"key":"106_CR17","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/nature03669","volume":"435","author":"F Michor","year":"2005","unstructured":"Michor F, Hughes TP, Iwasa Y, Branford S, Shah NP, Sawyers CL, Nowak M. A. Dynamics of chronic myeloid leukaemia. Nature. 2005; 435:1267\u201370.","journal-title":"Nature"},{"key":"106_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1742-4682-10-68","volume":"10","author":"S Kapoor","year":"2013","unstructured":"Kapoor S, Rallabandi VPs, Sakode C, Padhi R, PK Roy. A patient-specific therapeutic approach for tumour cell population extinction and drug toxicity reduction using control systems-based dose-profile design. Theor Biol Med Model. 2013; 10:68.","journal-title":"Theor Biol Med Model"},{"key":"106_CR19","volume-title":"The Cell: A Molecular Approach","author":"GM Cooper","year":"2000","unstructured":"Cooper GM. The Development and Causes of Cancer. In: The Cell: A Molecular Approach. 2nd. Sunderland (MA): Sinauer Associates: 2000."},{"issue":"121","key":"106_CR20","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1093\/annonc\/mdn424","volume":"19","author":"R Largillier","year":"2008","unstructured":"Largillier R, Ferrero JM, Doyen J, Barriere J, Namer M, Mari V, Courdi A, Hannoun-Levi JM, Ettore F, Birtwisle-Peyrottes I, Balu-Maestro C, Marcy PY, Raoust I, Lallement M, Chamorey E. Prognostic factors in 1038 women with metastatic breast cancer. Ann Oncol. 2008; 19(121):2012\u201319.","journal-title":"Ann Oncol"},{"issue":"5","key":"106_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1054\/bjoc.2000.1336","volume":"83","author":"P Symonds","year":"2000","unstructured":"Symonds P, Bolger B, Hole D, Mao JH, Cooke T. Advanced-stage cervix cancer: rapid tumour growth rather than late diagnosis. Brit J Cancer. 2000; 83(5):566\u20138.","journal-title":"Brit J Cancer"},{"issue":"5","key":"106_CR22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3747\/co.19.1043","volume":"19","author":"SA Narod","year":"2012","unstructured":"Narod SA. Tumour size predicts long-term survival among women with lymph node-positive breast cancer. Current Oncol. 2012; 19(5):249\u201353.","journal-title":"Current Oncol"},{"issue":"15","key":"106_CR23","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1200\/JCO.2017.35.15_suppl.3564","volume":"35","author":"C Schuurhuizen","year":"2017","unstructured":"Schuurhuizen C, Konings I, Braamse A, Buffart L, Bloemendal H, Dekker J, Verheul HMW. The impact of cumulative toxicity on physical quality of life in patients with metastatic colorectal cancer receiving first line chemotherapy. J Clin Oncol. 2017; 35(15):3564\u20134.","journal-title":"J Clin Oncol"},{"key":"106_CR24","volume-title":"Holland-Frei Cancer Medicine","author":"N Hanna","year":"2003","unstructured":"Hanna N, Timmerman R, Foster RS, Roth B. J, Einhorn LH, Nichols CR. Long-Term Toxicity of Chemotherapy. In: Holland-Frei Cancer Medicine. 6th. Hamilton (ON): BC Decker: 2003."},{"issue":"5","key":"106_CR25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1634\/theoncologist.7-suppl_5-11","volume":"7","author":"CJ Dunton","year":"2002","unstructured":"Dunton CJ. Management of Treatment-Related Toxicity in Advanced Ovarian Cancer. Oncol. 2002; 7(5):11\u201319.","journal-title":"Oncol"},{"issue":"9","key":"106_CR26","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1093\/annonc\/mdq715","volume":"22","author":"MS Marcolino","year":"2011","unstructured":"Marcolino MS, Boersma E, Clementino NCD, Macedo AV, Marx-Neto AD, M.Silva HCR, van Gelder T, Akkerhuis KM, Ribeiro AL. Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patients. Ann Oncol. 2011; 22(9):2073\u20139.","journal-title":"Ann Oncol"},{"issue":"2","key":"106_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4143\/crt.2007.39.2.61","volume":"39","author":"H-S Oh","year":"2007","unstructured":"Oh H-S, Chung H-J, Kim H-K, Choi J-S. Differences in Overall Survival When Colorectal Cancer Patients are Stratified into New TNM Staging Strategy. Cancer Res Treat. 2007; 39(2):61\u20134.","journal-title":"Cancer Res Treat"},{"issue":"7-8","key":"106_CR28","first-page":"391","volume":"109","author":"M Wahutu","year":"2016","unstructured":"Wahutu M, Vesely SK, Campbell J, Pate A, Salvatore AL, Janitz AE. Pancreatic Cancer: A Survival Analysis Study in Oklahoma. J Okl State Med Assoc. 2016; 109(7-8):391\u20138.","journal-title":"J Okl State Med Assoc"},{"issue":"1","key":"106_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/107327481402100107","volume":"21","author":"MB Schabath","year":"2014","unstructured":"Schabath MB, Thompson ZJ, Gray JE. Temporal trends in demographics and overall survival of non-small cell lung cancer patients at the Moffitt Cancer Center from 1986 to 2008. Cancer Cont. 2014; 21(1):51\u201356.","journal-title":"Cancer Cont"},{"key":"106_CR30","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/sj.bjc.6602590","volume":"92","author":"TF Gretenm","year":"2005","unstructured":"Gretenm TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S, Klempnauer J, Galanski M, Manns MP. Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Brit J Cancer. 2005; 92:1862\u20138.","journal-title":"Brit J Cancer"},{"issue":"51","key":"106_CR31","doi-asserted-by":"crossref","first-page":"89040","DOI":"10.18632\/oncotarget.21648","volume":"8","author":"X Wang","year":"2017","unstructured":"Wang X, Li X, Su S, Liu M. Marital status and survival in epithelial ovarian cancer patients: a SEER-based study. Oncotarget. 2017; 8(51):89040\u201354.","journal-title":"Oncotarget"},{"key":"106_CR32","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/annonc\/mdv107","volume":"26","author":"S Fisher","year":"2015","unstructured":"Fisher S, Gao H, Yasui Y, Dabbs K, Winget M. Survival in stage IIII breast cancer patients by surgical treatment in a publicly funded health care system. Ann Oncol. 2015; 26:1161\u20139.","journal-title":"Ann Oncol"},{"issue":"9","key":"106_CR33","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1182\/blood-2011-08-358135","volume":"119","author":"H Kantarjian","year":"2012","unstructured":"Kantarjian H, O\u2019Brien S, Jabbour E, Garcia-Manero G, Quintas-Cardama A, Shan J, Rios MB, Ravandi F, Faderl S, Kadia T, Borthakur G, Huang X, Champlin R, Talpaz M, Cortes J. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: A single-institution historical experience. Blood. 2012; 119(9):1981\u20137.","journal-title":"Blood"},{"issue":"2","key":"106_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/ajcp\/88.2.123","volume":"88","author":"J Russo","year":"1988","unstructured":"Russo J, Frederick J, Ownby HE, Fine G, Hussain M, Krickstein HI, Robbins TO, Rosenberg B. Predictors of recurrence and survival of patients with breast cancer. Am J Clin Pathol. 1988; 88(2):123\u201331.","journal-title":"Am J Clin Pathol"},{"key":"106_CR35","first-page":"1","volume":"12","author":"H Gona\u0327lves","year":"2018","unstructured":"Gona\u0327lves H, Guerra MR, Cintra JRD, Fayer VA, Brum IV, Teixeira MTB. Survival Study of Triple-Negative and Non Triple-Negative Breast Cancer in Brazilian Cohort. Clin Med Insig Oncol. 2018; 12:1\u201310.","journal-title":"Clin Med Insig Oncol"},{"issue":"2","key":"106_CR36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1590\/S0034-89102010000200016","volume":"44","author":"Arn Migowski","year":"2010","unstructured":"Migowski A, Silva GA. Survival of patients with clinically localized prostate cancer. Revista de Sa\u00fade P\u00fablica. 2010;44(2).","journal-title":"Revista de Sa\u00fade P\u00fablica"},{"issue":"2","key":"106_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/shem.2003.50037","volume":"40","author":"R Capdeville","year":"2003","unstructured":"Capdeville R, Silverman S. Imatinib: a targeted clinical drug development. Semin Hematol. 2003; 40(2):15\u201320.","journal-title":"Semin Hematol"},{"issue":"4","key":"106_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1053\/j.seminhematol.2010.06.001","volume":"47","author":"C Fava","year":"2010","unstructured":"Fava C, Saglio G. Can we and should we improve on frontline imatinib therapy for chronic myeloid leukemia?Semin Hematol. 2010; 47(4):319\u201326.","journal-title":"Semin Hematol"},{"volume-title":"Physycians\u2019 Desk Reference","year":"2010","key":"106_CR39","unstructured":"In: PDR Network, (ed).Physycians\u2019 Desk Reference, 64th ed. Montvale: LLC; 2010."},{"key":"106_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-72778-3","volume-title":"Dynamic Optimization and Differential Games","author":"TL Friesz","year":"2010","unstructured":"Friesz TL. Dynamic Optimization and Differential Games. New York: Springer; 2010."},{"key":"106_CR41","doi-asserted-by":"crossref","DOI":"10.1201\/9781420011418","volume-title":"Optimal Control Applied to Biological Models","author":"L Lenhart","year":"2007","unstructured":"Lenhart L, Workman JT. Optimal Control Applied to Biological Models. New York: Chapman & Hall; 2007."},{"key":"106_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12976-018-0097-6","volume":"16","author":"K Roosa","year":"2019","unstructured":"Roosa K, Chowell G. Assessing parameter identifiability in compartmental dynamic models using a computational approach: application to infectious disease transmission models. Theor Biol Med Model. 2019; 16:1.","journal-title":"Theor Biol Med Model"},{"key":"106_CR43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cmpb.2009.06.005","volume":"97","author":"C-L Chen","year":"2010","unstructured":"Chen C-L, Tsai H-W. Modeling the physiological glucose-insulin system on normal and diabetic subjects. Comput Meth Progr Biomed. 2010; 97:130\u201340.","journal-title":"Comput Meth Progr Biomed"},{"key":"106_CR44","volume-title":"Mecanismos Moleculares Implicados en la Regulaci\u00f3n de la Apoptosis y la Adhesi\u00f3n Celular por la Ruta c3g\/p38 Mapk: Implicaciones en la Patog\u00e9nesis de la Leucemia Mieloide Cr\u00f3nica","author":"VS Carneiro Maia","year":"2012","unstructured":"Carneiro Maia VS. Mecanismos Moleculares Implicados en la Regulaci\u00f3n de la Apoptosis y la Adhesi\u00f3n Celular por la Ruta c3g\/p38 Mapk: Implicaciones en la Patog\u00e9nesis de la Leucemia Mieloide Cr\u00f3nica. University of Salamanca: PhD dissertation; 2012."},{"issue":"17","key":"106_CR45","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.1182\/blood-2010-08-303537","volume":"117","author":"SN Catlin","year":"2011","unstructured":"Catlin SN, Busque L, RGale E, Guttorp P, Abkowitz JL. The Replication Rate of Human Hematopoietic Stem Cells in Vivo. Blood. 2011; 117(17):4460\u20136.","journal-title":"Blood"},{"key":"106_CR46","volume-title":"Medical Immunology","author":"T. G Parslow","year":"2001","unstructured":"Parslow T. G, Stites DP, Terr AI, Imboden JB. Medical Immunology. New York: Lange-McGraw-Hill; 2001."},{"key":"106_CR47","volume-title":"Functional Histology: A Text and Colour Atlas","author":"PR Wheater","year":"1987","unstructured":"Wheater PR, Burkitt HG, Daniels VG, Deakin PJ. Functional Histology: A Text and Colour Atlas. Edinburgh: Churchill Livingstone; 1987."},{"key":"106_CR48","unstructured":"European Medicines Agency. European public assessment report (EPAR) for Imatinib Accord. EMA\/102742;2017."},{"issue":"4","key":"106_CR49","first-page":"229","volume":"21","author":"D Murray Lyon","year":"1923","unstructured":"Murray Lyon D. Does the reaction to adrenalin obey Weber\u2019s Law?J Pharmacol Experiment Therapeut. 1923; 21(4):229\u201335.","journal-title":"J Pharmacol Experiment Therapeut"},{"issue":"4","key":"106_CR50","doi-asserted-by":"publisher","first-page":"048301","DOI":"10.1103\/PhysRevLett.107.048301","volume":"107","author":"M Inoue","year":"2011","unstructured":"Inoue M, Kaneko K. Weber\u2019s law for biological responses in autocatalytic networks of chemical reactions. Phys Rev Lett. 2011; 107(4):048301.","journal-title":"Phys Rev Lett"},{"issue":"2","key":"106_CR51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1023\/A:1026384519480","volume":"28","author":"HW Sinn","year":"2002","unstructured":"Sinn HW. Weber\u2019s law and the biological evolution of risk preferences: The selective dominance of the logarithmic utility function. Geneva Papers Risk Insur Theory. 2002; 28(2):87\u2013100.","journal-title":"Geneva Papers Risk Insur Theory"},{"key":"106_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12976-016-0029-2","volume":"13","author":"RJ Strilka","year":"2016","unstructured":"Strilka RJ, Stull MC, Clemens MS, McCaver SC, Armen SB. Simulation and qualitative analysis of glucose variability, mean glucose, and hypoglycemia after subcutaneous insulin therapy for stress hyperglycemia. Theor Biol Med Model. 2016; 13:3.","journal-title":"Theor Biol Med Model"},{"issue":"6","key":"106_CR53","doi-asserted-by":"publisher","first-page":"e222","DOI":"10.1111\/j.1751-553X.2010.01236.x","volume":"32","author":"PA Bartley","year":"2010","unstructured":"Bartley PA, Ross DM, Latham S, Martin-Harris MH, Budgen B, Wilczek V, Branford S, Hughes TP, Morley AA. Sensitive detection an quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA. Int J Laborat Hematol. 2010; 32(6):e222\u20138.","journal-title":"Int J Laborat Hematol"}],"container-title":["Theoretical Biology and Medical Modelling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12976-019-0106-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12976-019-0106-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12976-019-0106-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T19:17:39Z","timestamp":1663528659000},"score":1,"resource":{"primary":{"URL":"https:\/\/tbiomed.biomedcentral.com\/articles\/10.1186\/s12976-019-0106-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["106"],"URL":"https:\/\/doi.org\/10.1186\/s12976-019-0106-4","relation":{},"ISSN":["1742-4682"],"issn-type":[{"type":"electronic","value":"1742-4682"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"21 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the data employed in this article were generated through simulations or obtained from already published papers. Data are deemed to be exempt from institutional review board assessment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"10"}}